Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Dementia drug development aims to modulate pathological processes that cause clinical syndromes. Population data (epidemiological neuropathology) will help to model and predict the potential impact of such therapies on dementia burden in older people. Presently this can only be explored through post mortem findings. We report the attributable risks (ARs) for dementia at death for common age-related degenerative and vascular pathologies, and other factors, in the MRC Cognitive Function and Ageing Study (MRC CFAS). METHODS AND FINDINGS: A multicentre, prospective, longitudinal study of older people in the UK was linked to a brain donation programme. Neuropathology of 456 consecutive brain donations assessed degenerative and vascular pathologies. Logistic regression modelling, with bootstrapping and sensitivity analyses, was used to estimate AR at death for dementia for specific pathologies and other factors. The main contributors to AR at death for dementia in MRC CFAS were age (18%), small brain (12%), neocortical neuritic plaques (8%) and neurofibrillary tangles (11%), small vessel disease (12%), multiple vascular pathologies (9%), and hippocampal atrophy (10%). Other significant factors include cerebral amyloid angiopathy (7%) and Lewy bodies (3%). CONCLUSIONS: Such AR estimates cannot be derived from the living population; rather they estimate the relative contribution of specific pathologies to dementia at death. We found that multiple pathologies determine the overall burden of dementia. The impact of therapy targeted to a specific pathology may be profound when the dementia is relatively "pure," but may be less impressive for the majority with mixed disease, and in terms of the population. These data justify a range of strategies, and combination therapies, to combat the degenerative and vascular determinants of cognitive decline and dementia. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [102]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the specific importance of subcortical infarcts and interaction has not been confirmed, subsequent studies have established that infarcts are additive with Alzheimer disease pathology in lowering cognitive function17,57 and increasing the odds of dementia17,18,62,63 or clinical Alzheimer disease.61”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“both lead to cognitive decline and dementia”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, the density of tau-positive NPs does correlate directly and statistically independently with some degree of cognitive impairment (105-107) (Fig. 2).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [107]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Multiple imputation after 18+ years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476908 · Cited by 4,072
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationMultiple Imputation After 18+ Years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.2307/2291635 · Cited by 2,686
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Cited by
Items 101–200 of 285
Quantitative gait, cognitive decline, and incident dementia: The Rotterdam Study
Darweesh, S. K. L., Licher, S., Wolters, F. J., Koudstaal, P. J., Ikram, M. K., & Ikram, M. A. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.03.013 · Cited by 70
Body weight variability in midlife and risk for dementia in old age
Ravona‐Springer, R., Beeri, M. S., & Goldbourt, U. (2013) · Neurology · doi:10.1212/wnl.0b013e3182904cee · Cited by 66
Edwards, L., Joie, R. L., Iaccarino, L., Strom, A., Baker, S. L., Casaletto, K. B., Cobigo, Y., Grant, H. E., Kim, M., Kramer, J. H., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.003 · Cited by 70
Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology
Horsburgh, K. J., Wardlaw, J. M., Agtmael, T. V., Allan, S. M., Ashford, M. L. J., Bath, P. M., Brown, R., Berwick, J., Cader, M. Z., Carare, R. O., et al. (2018) · Clinical Science · doi:10.1042/cs20171620 · Cited by 68
Smith, E. E., Aparicio, H. J., Gottesman, R. F., Goyal, M. S., Greenberg, S. M., Schneider, J. A., Sorond, F. A., & Wright, C. B. (2025) · Stroke · doi:10.1161/str.0000000000000494 · Cited by 81
Bennett, D. A. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002256 · Cited by 61
Richardson, K., Stephan, B. C. M., Ince, P. G., Brayne, C., Matthews, F. E., & Esiri, M. M. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322654 · Cited by 64
Self-citationon behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group, Wharton, S. B., Minett, T., Drew, D., Forster, G., Matthews, F. E., Brayne, C., & Ince, P. G. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0275-x · Cited by 65
Self-citationTherapeutic Strategies and Drug Development for Vascular Cognitive Impairment
Smith, E. E., Cieślak, A., Barber, P. A., Chen, J. Y., Chen, Y., Donnini, I., Edwards, J. D., Frayne, R., Field, T. S., Hegedus, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005568 · Cited by 61
Glymphatic system dysfunction in neurodegenerative diseases
Beschörner, N., & Nedergaard, M. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001252 · Cited by 66
Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease
Ameen‐Ali, K. E., Wharton, S. B., Simpson, J. E., Heath, P. R., Sharp, P., & Berwick, J. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12440 · Cited by 60
Self-citationInce, P. G., Minett, T., Forster, G., Brayne, C., & Wharton, S. B. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12363 · Cited by 59
Self-citationRoyall, D., & Palmer, R. F. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.11.009 · Cited by 48
Postmortem neurodegenerative markers and trajectories of decline in cognitive systems
Wilson, R. S., Yang, J., Yu, L., Leurgans, S. E., Capuano, A. W., Schneider, J. A., Bennett, D. A., & Boyle, P. A. (2019) · Neurology · doi:10.1212/wnl.0000000000006949 · Cited by 54
Kitamura, A., Manso, Y., Duncombe, J., Searcy, J. L., Koudelka, J., Binnie, M., Webster, S. P., Lennen, R. J., Jansen, M. A., Marshall, I., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04082-0 · Cited by 51
Schreiber, S., Wilisch-Neumann, A., Schreiber, F., Assmann, A., Scheumann, V., Perosa, V., Jandke, S., Mawrin, C., Carare, R. O., & Werring, D. J. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12576 · Cited by 55
Walsh, S., Causer, R., & Brayne, C. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1699019 · Cited by 51
Self-citationOperationalized definition of older adults with high cognitive performance
Borelli, W. V., Carmona, K. C., Studart‐Neto, A., Nitríni, R., Caramelli, P., & da Costa, J. C. (2018) · Dementia & Neuropsychologia · doi:10.1590/1980-57642018dn12-030001 · Cited by 52
Walker, L., & Attems, J. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-230154 · Cited by 53
Uetani, H., Hirai, T., Hashimoto, M., Ikeda, M., Kitajima, M., Sakamoto, F., Utsunomiya, D., Oda, S., Sugiyama, S., Matsubara, J., et al. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3332 · Cited by 48
Hippocampal sclerosis, hippocampal neuron loss patterns and TDP‐43 in the aged population
Hokkanen, S. R. K., Hunter, S., Polvikoski, T. M., Keage, H. A. D., Minett, T., Matthews, F. E., Brayne, C., & MRC CFAS and CC75C Study Group (2018) · Brain Pathology · doi:10.1111/bpa.12556 · Cited by 47
Self-citationAlpha Synuclein in Parkinson’s Disease
Kragh, C. L., Romero‐Ramos, M., Halliday, G. M., & Jensen, P. H. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_14 · Cited by 49
Calcium dysregulation in relation to Alzheimer‐type pathology in the ageing brain
Garwood, C., Faizullabhoy, A., Wharton, S. B., Ince, P. G., Heath, P. R., Shaw, P. J., Baxter, L., Gelsthorpe, C., Forster, G., Matthews, F. E., et al. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12033 · Cited by 47
Self-citationβ-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates
Woo, J. A., Liu, T., Fang, C. C., Castaño, M. A., Kee, T. R., Yrigoin, K., Yan, Y., Cazzaro, S., Matlack, J. K., Wang, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917194117 · Cited by 48
Spherulites of Amyloid-β42 In Vitro and in Alzheimer's Disease
Exley, C., House, E. R., Collingwood, J. F., Davidson, M. R., Cannon, D., & Donald, A. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091630 · Cited by 46
Jandke, S., Garz, C., Schwanke, D., Sendtner, M., Heinze, H., Carare, R. O., & Schreiber, S. (2018) · Brain Pathology · doi:10.1111/bpa.12629 · Cited by 47
Obesity and Longer Term Risks of Dementia in 65–74 Year Olds
Bowman, K., Thambisetty, M., Kuchel, G. A., Ferrucci, L., & Melzer, D. R. (2019) · Age and Ageing · doi:10.1093/ageing/afz002 · Cited by 49
Mytton, O. T., Jackson, C. H., Steinacher, A., Goodman, A., Langenberg, C., Griffin, S. J., Wareham, N. J., & Woodcock, J. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002517 · Cited by 50
Nelson, R. S., Abner, E. L., Jicha, G. A., Schmitt, F. A., Di, J., Wilcock, D. M., Barber, J. M., Eldik, L. J. V., Katsumata, Y., Fardo, D. W., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01576-z · Cited by 45
Jäkel, L., Kuiperij, H. B., Gerding, L. P., Custers, E., van den Berg, E., Jolink, W. M. T., Schreuder, F. H. B. M., Küsters, B., Klijn, C. J. M., & Verbeek, M. M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00972-z · Cited by 45
Study, T. C. F. A. A., Bury, J. J., Chambers, A., Heath, P. R., Ince, P. G., Shaw, P. J., Matthews, F. E., Brayne, C., Simpson, J. E., & Wharton, S. B. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01109-y · Cited by 46
Self-citationHunter, S., Arendt, T., & Brayne, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8445-3 · Cited by 44
Self-citationBrookmeyer, R., Kawas, C. H., Abdallah, N., Paganini‐Hill, A., Kim, R. C., & Corrada, M. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.004 · Cited by 40
Nicoll, J. A. R., Savva, G. M., Stewart, J., Matthews, F. E., Brayne, C., & Ince, P. G. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01130.x · Cited by 47
Self-citationA European perspective on population studies of dementia
Brayne, C., Stephan, B. C. M., & Matthews, F. E. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.003 · Cited by 40
Self-citationBonifacio, G., & Zamboni, G. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133759 · Cited by 46
Stephan, B. C. M., The Medical Research Council Cognitive Function and Ageing Neuropathology Study, Matthews, F. E., Ma, B., Muniz, G., Hunter, S., Davis, D., McKeith, I. G., Foster, G., Ince, P. G., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110518 · Cited by 38
Self-citationShabir, O., Pendry, B., Lee, L., Eyre, B., Sharp, P. S., Rebollar, M. A., Drew, D., Howarth, C., Heath, P. R., Wharton, S. B., et al. (2022) · eLife · doi:10.7554/elife.68242 · Cited by 40
“Population- based studies have shown that AD and vascular pathologies commonly coexist in the brains of elderly individuals (Kapasi et al., 2017; Matthews et al., 2009; Neuropathology Group. Medical Research Council Cognitive and Aging, 2001; Rahimi and Kovacs, 2014).”
BackgroundSelf-citationSamarasekera, N., Rodrigues, M. A., Toh, P. S., & Salman, R. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180923 · Cited by 45
Archer, H. A., Smailagic, N., John, C., Holmes, R. B., Takwoingi, Y., Coulthard, E. J., & Cullum, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010896.pub2 · Cited by 37
Arévalo-Rodríguez, I., Smailagic, N., Ciapponi, A., Sanchez-Perez, E., Giannakou, A., Figuls, M. R. I., Pedraza, O. L., Bonfill, X., & Cullum, S. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010783 · Cited by 45
Matuszyk, M. M., Garwood, C. J., Ferraiuolo, L., Simpson, J. E., Staniforth, R. A., & Wharton, S. B. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15538 · Cited by 38
Self-citationNew horizons: the management of hypertension in people with dementia
Harrison, J. K., van der Wardt, V., Conroy, S., Stott, D. J., Dening, T., Gordon, A. L., Logan, P., Welsh, T. J., Taggar, J., Harwood, R., et al. (2016) · Age and Ageing · doi:10.1093/ageing/afw155 · Cited by 40
Howe, M. D., Atadja, L. A., Furr, J. W., Maniskas, M. E., Zhu, L., McCullough, L. D., & Urayama, A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.019 · Cited by 36
Henriques, A. D., Machado‐Silva, W., Leite, R. E. P., Suemoto, C. K., Leite, K. R. M., Srougi, M., Pereira, A. C., Filho, W. J., & Nóbrega, O. D. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111352 · Cited by 47
Walker, L., Simpson, H., Thomas, A. J., & Attems, J. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01714-7 · Cited by 39
Neuropathological Changes in Aging Brain
Xekardaki, A., Kövari, E., Gold, G., Papadimitropoulou, A., Giacobini, E., Herrmann, F. R., Giannakopoulos, P., & Bouras, C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-08939-3_6 · Cited by 37
Smith, E. E. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000304 · Cited by 47
Interpretable deep learning of myelin histopathology in age-related cognitive impairment
McKenzie, A. T., Marx, G. A., Koenigsberg, D., Sawyer, M., Iida, M. A., Walker, J. M., Richardson, T. E., Campanella, G. S. V., Attems, J., McKee, A. C., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01425-5 · Cited by 36
White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease
Compta, Y., Buongiorno, M., Bargalló, N., Valldeoriola, F., Muñoz, E., TOLOSA, E. S., Ríos, J., Cámara, A., Fernández, M., & Martí, M. J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.06.009 · Cited by 37
Bennett, D. A. (2018) · JAMA · doi:10.1001/jama.2017.19700 · Cited by 33
Azarpazhooh, M. R., Avan, A., Cipriano, L. E., Munoz, D. G., Erfanian, M., Amiri, A., Stranges, S., & Hachinski, V. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.101002 · Cited by 32
on behalf of the Cognitive Function and Ageing Neuropathology Study Group, Wharton, S. B., Wang, D. Y. Q., Parikh, C. R., Matthews, F. E., Brayne, C., & Ince, P. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0858-4 · Cited by 34
Self-citationDementia and Alzheimer's disease: A new direction. The 2010 Jay L. Foster Memorial Lecture
Kuller, L. H., & López, O. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.901 · Cited by 36
Ritchie, C. W., Smailagic, N., Ladds, E. C., Noel-Storr, A. H., Ukoumunne, O. C., & Martin, S. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010803 · Cited by 31
Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium
Chibnik, L. B., Wolters, F. J., Bäckman, K., Beiser, A., Berr, C., Bis, J. C., Boerwinkle, E., Bos, D., Brayne, C., Dartigues, J., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0320-5 · Cited by 36
Self-citationDevelopment of a Multicomponent Intervention to Prevent Alzheimer's Disease
Saitô, S., Yamamoto, Y., & Ihara, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00490 · Cited by 31
Robinson, A. C., Davidson, Y. S., Horan, M. A., Pendleton, N., & Mann, D. M. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180171 · Cited by 31
Chronic Vitamin C Deficiency does not Accelerate Oxidative Stress in Ageing Brains of Guinea Pigs
Tveden‐Nyborg, P., Hasselholt, S., Miyashita, N., Moos, T., Poulsen, H. E., & Lykkesfeldt, J. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00852.x · Cited by 34
Kandasamy, M., Radhakrishnan, R. K., Abirami, G. P. P., Roshan, S. A., Yesudhas, A., Kadalmani, B., Prahalathan, C., Sellathamby, S., Moorthy, A., Essa, M. M., et al. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02833-1 · Cited by 28
Hachinski, V., Einhäupl, K. M., Ganten, D., Alladi, S., Brayne, C., Stephan, B. C. M., Sweeney, M. D., Zloković, B. V., Iturria‐Medina, Y., Iadecola, C., et al. (2019) · International Journal of Stroke · doi:10.1177/1747493019871915 · Cited by 30
Self-citationInsights into the pathological basis of dementia from population‐based neuropathology studies
Wharton, S. B., Simpson, J. E., Ince, P. G., Richardson, C. D., Merrick, R. L., Matthews, F. E., Brayne, C., & CFAS (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12923 · Cited by 28
Self-citationDerby, C. A. (2020) · Current Epidemiology Reports · doi:10.1007/s40471-020-00231-8 · Cited by 30
Creavin, S., Noel-Storr, A. H., Smailagic, N., Giannakou, A., Ewins, E., Wisniewski, S., & Cullum, S. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011145 · Cited by 29
Vascular Risk Factors as Treatment Target to Prevent Cognitive Decline
Richard, E., van Charante, E. P. M., & van Gool, W. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120772 · Cited by 29
Imaging Approaches for Dementia
Murray, A. D. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2782 · Cited by 27
Xiong, X., Hu, T., Yin, Z., Zhang, Y., Chen, F., & Lei, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.944283 · Cited by 28
Alzheimer's Disease and Its Potential Alternative Therapeutics.
Kisby, B. R., Jarrell, J. T., Me, A., Ds, C., Er, R., Cm, C., Rogers, J. T., & Huang, X. (2019) · PubMed · doi:10.4172/2161-0460.1000477 · Cited by 27
King, D. L. O., Henson, R. N., Kievit, R., Wolpe, N., Brayne, C., TYLER, L. K., Rowe, J. B., Cam‐CAN, Bullmore, E. T., Calder, A. J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-27252-1 · Cited by 27
Self-citationNeuropathological Profile of Mild Cognitive Impairment From a Population Perspective
Stephan, B. C. M., Matthews, F. E., Hunter, S., Savva, G. M., Bond, J., McKeith, I. G., Ince, P. G., & Brayne, C. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31822fc24d · Cited by 23
Self-citationThe Ameliorating Effects of Bee Pollen on Scopolamine-Induced Cognitive Impairment in Mice
Liao, Y., Bae, H. J., Zhang, J., Kwon, Y., Koo, B., Jung, I. H., Kim, H. M., Park, J. H., Lew, J. H., & Ryu, J. H. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00552 · Cited by 22
Impaired Cerebral Autoregulation in Alzheimer’s Disease: A Transcranial Doppler Study
Zhou, G., Zhao, X., Lou, Z., Zhou, S., Shan, P., Zheng, N., Yu, X., & Ma, L. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190296 · Cited by 22
Assessment of Alzheimer-related pathologies of dementia using machine learning feature selection
Rajab, M. A., Jammeh, E., Taketa, T., Brayne, C., Matthews, F. E., Su, L., Ince, P. G., Wharton, S. B., Wang, D. Y. Q., & on behalf of the Cognitive Function and Ageing Neuropathology Study Group (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01195-9 · Cited by 25
Self-citationBurton, J. K., Fearon, P. A., Noel-Storr, A. H., McShane, R. H., Stott, D. J., & Quinn, T. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010772.pub3 · Cited by 26
Ortner, M., Kurz, A., Alexopoulos, P., Auer, F., Diehl-Schmid, J., Drzezga, A., Förster, S., Förstl, H., Perneczky, R., Sorg, C., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.019 · Cited by 17
Bun, S., Ikejima, C., Kida, J., Yoshimura, A., Lebowitz, A., Kakuma, T., & Asada, T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142232 · Cited by 17
Waller, R., Narramore, R., Simpson, J. E., Heath, P. R., Verma, N., Tinsley, M., Barnes, J. R., Haris, H. T., Henderson, F. E., Matthews, F. E., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12928 · Cited by 18
Self-citationAssociation between diabetes and causes of dementia: Evidence from a clinicopathological study
Matioli, M. N. P. D. S., Suemoto, C. K., Rodriguez, R. D., Farias, D. S., da Silva, M. M., Leite, R. E. P., Ferretti‐Rebustini, R. E. D. L., Pasqualucci, C. A., Filho, W. J., Grinberg, L. T., et al. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-040010 · Cited by 19
de Abreu, D. C. C., Pieruccini‐Faria, F., Son, S., Montero‐Odasso, M., & Camicioli, R. M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105677 · Cited by 19
Evaluation of routinely collected records for dementia outcomes in UK: a prospective cohort study
Hayat, S. A., Luben, R., Khaw, K., Wareham, N. J., & Brayne, C. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-060931 · Cited by 20
Self-citationChambers, A., Bury, J. J., Minett, T., Richardson, C. D., Brayne, C., Ince, P. G., Shaw, P. J., Garwood, C. J., Heath, P. R., Simpson, J. E., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa064 · Cited by 16
Self-citationGicas, K. M., Honer, W. G., Wilson, R. S., Boyle, P. A., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2020) · Neurology · doi:10.1212/wnl.0000000000010952 · Cited by 15
Metabolic-Cognitive Syndrome: Metabolic Approach for the Management of Alzheimer's Disease Risk
Frisardi, V., & Imbimbo, B. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120811 · Cited by 16
Prevención de la enfermedad de Alzheimer: un camino a seguir
Bermejo‐Pareja, F., Velasco, S. L., & Villarejo‐Galende, A. (2016) · Revista Clínica Española · doi:10.1016/j.rce.2016.05.010 · Cited by 25
Leirós, B. G., Pérez‐Méndez, L., Zelaya, M. V., Eguinoa, L. M., García-Bragado, F., Álvarez, T. T., & Larreta, J. J. R. (2016) · Neurología · doi:10.1016/j.nrl.2016.04.011 · Cited by 14
Leirós, B. G., Méndez, L. I. P., Huerta, M. V. Z., Eguinoa, L. M., García-Bragado, F., Álvarez, T. T., & Larreta, J. J. R. (2017) · Neurología (English Edition) · doi:10.1016/j.nrleng.2016.04.004 · Cited by 14
(1982) · NASSP Bulletin · doi:10.1177/019263658206645308 · Cited by 13
Clinical history for diagnosis of dementia in men: Caerphilly Prospective Study
Creavin, S., Fish, M., Gallacher, J., Bayer, A. J., & Ben‐Shlomo, Y. (2015) · British Journal of General Practice · doi:10.3399/bjgp15x686053 · Cited by 13
Muzumdar, R. H., & Atzmo, G. (2012) · InTech eBooks · doi:10.5772/53227 · Cited by 11
Dementia in the older population is associated with neocortex content of serum amyloid P component
Ellmerich, S., Taylor, G. W., Richardson, C. D., Minett, T., Schmidt, A. F., Brayne, C., Matthews, F. E., Ince, P. G., Wharton, S. B., Pepys, M. B., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab225 · Cited by 11
Self-citationCognitive resilience in ageing: determinants and interventions
Powell, A., Chan, K., Shepherd, C. E., & Brodaty, H. (2026) · The Lancet Neurology · doi:10.1016/s1474-4422(26)00027-x · Cited by 13
Johnson, E. E. H., Alexander, C., Lee, G. J., Angers, K., Ndiaye, D., & Suhr, J. A. (2021) · The Clinical Neuropsychologist · doi:10.1080/13854046.2021.1940299 · Cited by 10
Cognitive deficits in Parkinson’s disease: current perspectives
Cosgrove, J., & Alty, J. (2018) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s125064 · Cited by 12
Fadul, M. M., Heath, P. R., Cooper‐Knock, J., Kurz, J. M., Al-Azzawi, H. A., Ali, Z., Smith, T., Matthews, F. E., Brayne, C., Wharton, S. B., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217924 · Cited by 10
Self-citationCognitive Outcomes of Cardiovascular Surgical Procedures in the Old: An Important but Neglected Area
Keage, H. A. D., Smith, A. E., Loetscher, T., & Psaltis, P. J. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.09.002 · Cited by 10
Robinson, A., Chew-Graham, S., Davidson, Y. S., Horan, M. A., Roncaroli, F., Minshull, J., du Plessis, D., Pal, P., Payton, A., Pendleton, N., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190580 · Cited by 9
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use
Richardson, K., Wharton, S. B., Grossi, C. M., Matthews, F. E., Fox, C., Maidment, I., Loke, Y. K., Steel, N., Arthur, A. J., Myint, P. K., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191199 · Cited by 9
Self-citationGicas, K. M., Honer, W. G., Leurgans, S. E., Wilson, R. S., Boyle, P. A., Schneider, J. A., & Bennett, D. A. (2022) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617722000595 · Cited by 9
Alzheimer's disease prevention: A way forward
Bermejo‐Pareja, F., Velasco, S. L., & Villarejo‐Galende, A. (2016) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2016.06.006 · Cited by 13
Robinson, A., Roncaroli, F., Chew-Graham, S., Davidson, Y. S., Minshull, J., Horan, M. A., Payton, A., Pendleton, N., & Mann, D. M. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200339 · Cited by 9
Metadata
- Authors
- Matthews, F. E., Brayne, C., Lowe, J., McKeith, I., Wharton, S. B., & Ince, P.
- Affiliations
- University of Cambridge (GB)
- University of Nottingham (GB)
- Newcastle University (GB)
- University of Sheffield (GB)
- Corresponding author
- Ince, Paul
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-11-10
- Volume
- 6
- Issue
- 11
- Pages
- e1000180
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC2765638
- OpenAlex
- W2039937642
- Cited by
- 279
- References
- 40
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 8 · 2023: 12 · 2022: 15 · 2021: 19 · 2020: 20 · 2019: 23 · 2018: 15 · 2017: 23 · 2016: 28 · 2015: 10 · 2014: 20 · 2013: 19 · 2012: 20
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council (G9901400)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia, neuropathology, attributable risk, vascular pathology, cerebral small vessel disease, cerebral amyloid angiopathy, Lewy bodies, neurofibrillary tangles, hippocampal atrophy, brain donation, MRC Cognitive Function and Ageing Study, dementia burden, combination therapy
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Aging, Brain, Death, Dementia, Female, United Kingdom, Humans, Longitudinal Studies, Male, Organ Size, Prospective Studies, Risk Factors, Sensitivity and Specificity, Vascular Diseases, Logistic Models, Lewy Bodies, Cerebral Amyloid Angiopathy, Neurofibrillary Tangles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

